News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,391 Results
Type
Article (40934)
Company Profile (267)
Press Release (681180)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204759)
Career Advice (2025)
Deals (35534)
Drug Delivery (111)
Drug Development (81386)
Employer Resources (173)
FDA (16417)
Job Trends (14948)
News (346499)
Policy (32734)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2571)
Accelerated approval (34)
Adcomms (24)
Allergies (143)
Alliances (49582)
ALS (170)
Alzheimer's disease (1676)
Antibody-drug conjugate (ADC) (314)
Approvals (16688)
Artificial intelligence (520)
Autoimmune disease (159)
Automation (42)
Bankruptcy (361)
Best Places to Work (11637)
BIOSECURE Act (20)
Biosimilars (192)
Biotechnology (174)
Bladder cancer (159)
Brain cancer (57)
Breast cancer (642)
Cancer (4846)
Cardiovascular disease (406)
Career advice (1710)
Career pathing (36)
CAR-T (283)
CDC (45)
Celiac Disease (2)
Cell therapy (748)
Cervical cancer (36)
Clinical research (69613)
Collaboration (1716)
Company closure (4)
Compensation (1172)
Complete response letters (57)
COVID-19 (2714)
CRISPR (93)
C-suite (863)
Cystic fibrosis (143)
Data (6288)
Decentralized trials (2)
Denatured (25)
Depression (134)
Diabetes (504)
Diagnostics (6710)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (255)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (90312)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117460)
Executive appointments (980)
FDA (19560)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1479)
Gene editing (199)
Generative AI (44)
Gene therapy (597)
GLP-1 (967)
Government (4664)
Grass and pollen (6)
Guidances (384)
Healthcare (18880)
HIV (62)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (254)
Immuno-oncology (58)
Indications (118)
Infectious disease (2989)
Inflammatory bowel disease (193)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (254)
Interviews (316)
IPO (16643)
IRA (50)
Job creations (3643)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (547)
Leadership (32)
Legal (7955)
Liver cancer (91)
Longevity (15)
Lung cancer (655)
Lymphoma (379)
Machine learning (42)
Management (59)
Manufacturing (808)
MASH (164)
Medical device (13781)
Medtech (13837)
Mergers & acquisitions (19967)
Metabolic disorders (1274)
Multiple sclerosis (164)
NASH (16)
Neurodegenerative disease (320)
Neuropsychiatric disorders (88)
Neuroscience (2918)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4515)
Now hiring (68)
Obesity (598)
Opinion (262)
Ovarian cancer (167)
Pain (199)
Pancreatic cancer (230)
Parkinson's disease (282)
Partnered (33)
Patents (507)
Patient recruitment (496)
Peanut (56)
People (58937)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21701)
Phase 2 (30636)
Phase 3 (22824)
Pipeline (5425)
Policy (285)
Postmarket research (2564)
Preclinical (9202)
Press Release (64)
Prostate cancer (240)
Psychedelics (48)
Radiopharmaceuticals (283)
Rare diseases (846)
Real estate (5955)
Recruiting (70)
Regulatory (24539)
Reports (53)
Research institute (2391)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (80)
Schizophrenia (148)
Series A (240)
Series B (191)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3615)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1012)
Venture capital (89)
Weight loss (381)
Women's health (93)
Worklife (18)
Date
Today (149)
Last 7 days (562)
Last 30 days (2373)
Last 365 days (29911)
2026 (3937)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35021)
2017 (32115)
2016 (31495)
2015 (37558)
2014 (31333)
2013 (26354)
2012 (28587)
2011 (29281)
2010 (27346)
Location
Africa (736)
Alabama (84)
Alaska (7)
Arizona (310)
Arkansas (13)
Asia (39237)
Australia (6414)
California (11386)
Canada (3313)
China (1103)
Colorado (480)
Connecticut (483)
Delaware (340)
Europe (84600)
Florida (1708)
Georgia (360)
Hawaii (3)
Idaho (61)
Illinois (869)
India (69)
Indiana (526)
Iowa (22)
Japan (436)
Kansas (127)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1394)
Massachusetts (8146)
Michigan (327)
Minnesota (631)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (3023)
New Mexico (28)
New York (3002)
North Carolina (1465)
North Dakota (8)
Northern California (5572)
Ohio (337)
Oklahoma (21)
Oregon (41)
Pennsylvania (2303)
Puerto Rico (24)
Rhode Island (48)
South America (1109)
South Carolina (67)
South Dakota (1)
Southern California (4434)
Tennessee (177)
Texas (1755)
United States (40363)
Utah (340)
Vermont (1)
Virginia (264)
Washington D.C. (81)
Washington State (926)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
722,391 Results for "orthofix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orthofix Reports Third Quarter 2025 Financial Results
November 5, 2025
·
18 min read
Press Releases
Orthofix to Participate in Upcoming November 2025 Investor Conferences
October 16, 2025
·
1 min read
Press Releases
Orthofix Reports Second Quarter 2025 Financial Results
August 6, 2025
·
18 min read
Business
Aviva McPherron Joins Orthofix as President of Global Operations and Quality
Orthofix Medical Inc today announced the appointment of Aviva McPherron as President of Global Operations and Quality.
June 18, 2024
·
5 min read
Business
Michael Finegan Named Chair of the Orthofix Board of Directors
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Michael Finegan as Chair of the Board of Directors.
June 24, 2024
·
4 min read
Business
Orthofix Names Max Reinhardt President of Global Spine Business
Orthofix Medical Inc today announced the appointment of Max Reinhardt as President of the Global Spine business effective June 10, 2024.
May 23, 2024
·
4 min read
Business
Orthofix Reports First Quarter 2024 Results
Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
13 min read
Press Releases
Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System
June 17, 2025
·
5 min read
Press Releases
Orthofix Reports First Quarter 2025 Financial Results
May 6, 2025
·
18 min read
Press Releases
Orthofix to Report First Quarter 2025 Financial Results
April 15, 2025
·
1 min read
1 of 72,240
Next
